FDA Inspection 1302124 — Catalent France Beinheim SA

Catalent France Beinheim SA — FEI 3002808036

The FDA completed an inspection of Catalent France Beinheim SA on November 25, 2022 in Beinheim. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 25, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Beinheim (France)

Additional Details

Mutual Recognition Agreement (MRA)